<p>The synthesis of novel oxadiazole antibiotics more water soluble than previously published analogues within the group will be discussed in this thesis as part of synthesizing a library with increased sp3 character.  These analogues were tested against S. aureus and MRSA strains to determine the most active compounds then percent hemolysis confirmed little RBC lysis among the compounds.  Synergistic activity was also tested for HSGN-2241 previously synthesized within the group.  Biofilm eradication assays were completed for HSD 1919 alongside time kill assays.</p>

A interação de várias substancias bioativas com monocamadas de fosfolipídios foi investigada usando isotermas de pressão e potencial de superfície, incluindo as drogas farmacológicas dipiridamol (DIP), clopromazina (CPZ) e trifluoperazina (TFP), além da melatonina (MEL) e o colesterol (COL). Os fosfolipídios empregados foram o zwiteriônico dipalmitoil fosfatidil colina (DPPC) e o aniônico dipalmitoil fosfatidil glicerol (DPPG) espalhados na superfície de água ultrapura, sendo que as monocamadas servem como modelo simples de membranas. A cooperatividade na interação entre fosfolipídios e moléculas com atividade biológica foi essencial para entender os acentuados efeitos na expansão (ou condensação) das monocamadas e as mudanças no momento de dipolo (até 10% de aumento na expansão em relação à monocamada do fosfolipídio puro para as misturas DIP/DPPC) que ocorreram a concentrações molares muito baixas entre 0,2-0,4% do DIP. Tais efeitos foram observados para todas as cinco substâncias investigadas, em todos os regimes de pressão. Nas altas concentrações, o comportamento da interação depende do tipo de mólecula e também de se a monocamada é de DPPC ou DPPG. Para o DPPC, as drogas farmacológicas foram expelidas da interface em vários graus a altas pressões, e existia um máximo de concentração da droga acima do qual ocorria a saturação, provavelmente porque as moléculas em excesso foram para a subfase. Essas concentrações críticas foram de 2% em mol para o DIP e a CPZ e de 5% em mol para a TFP. Para o DIP, em particular, os resultados das isotermas foram correlacionados com experimentos de espectroscopia de FTIR e microscopia de fluorescência \"in situ\", realizados por colaboradores, os quais permitiram a determinação de uma localização precisa da droga estudada. Não existe inserção do DIP na região da cauda hidrofóbica da monocamada do DPPC, com a interação ocorrendo com o grupo fosfato no zwiteríon, cujas pequenas mudanças na orientação induzidas pelo DIP levam a grandes mudanças no momento de dipolo. Como o DPPG está carregado negativamente sobre a superfície da água pura, não existe saturação nos efeitos de expansão com o aumento da concentração das drogas. O aumento do momento de dipolo efetivo na monocamada mista é atribuído a alterações na densidade de carga superficial pela adsorção da droga catiônica, que reduz a contribuição negativa do potencial da dupla camada, quando comparado com o da monocamada de DPPG puro. Os resultados do COL e a MEL devem ser considerados separadamente devido a sua natureza distinta, embora um comportamento cooperativo também tenha observado com grandes efeitos nas baixas concentrações. Tanto o COL como o MEL induzem mudanças na expansão das monocamadas de DPPC até a máxima concentração empregada, 20% molar. Para o COL foi observado um efeito de condensação a baixas concentrações, o qual foi seguido por uma expansão a altas concentrações, confirmando assim resultados prévios da literatura. Todas as monocamadas mistas COL/DPPG apresentavam-se expandidas, também confirmando alguns resultados da literatura para lipídios (diferentes do DPPC) quando misturados com o COL. A interação da MEL com o DPPC foi essencialmente similar à do COL, apesar do fato de a MEL pura não formar monocamadas estáveis. Sua interação com o DPPG foi peculiar já que o efeito que esta induz satura a 5% em mol. Isto também difere do comportamento das drogas farmacológicas. A MEL é neutra em todos os pHs, portanto, sua intenção com as membranas modelo de DPPG e DPPC só pode ocorrer via dipolo. O mesmo se aplica ao colesterol, o que justifica as diferenças no comportameto destas duas moléculas quando comparadas com as drogas (DIP, CPZ, TFP), que são carregadas sobre a água pura, nas misturas com os dois fosfolipídios (DPPG e DPPC). / The interaction of various bioactive substances with phospholipids monolayers has been investigated using surface pressure and surface potential isotherms, which include the pharmaceutical drugs dipyridamole (DIP), chlorpromazine (CPZ) and trifluoperazine (TFP), in addition to melatonin (MEL) and cholesterol (COL). The phospholipids employed were the zwitterionic dipalmitoyl phosphatidyl choline (DPPC) and the anionic dipalmitoyl phosphatidyl glycerol (DPPG) spread onto ultra pure water surfaces, where the monolayers served as simple model membrane systems. Cooperativity in the interaction between phospholipid and bioactive molecules was essential to account for the large effects of expansion (up to 10% increase in area in relation to the pure phospholipid monolayer for the DIP/DPPC mixture) of the monolayers and changes in dipole moment, which occurred at very low concentrations, e.g. 0.2 - 0.4 mol% of the substance. Such large effects were observed for all 5 substances investigated, at all surface pressure regimes. At higher concentrations, the interaction behavior depended on the type of molecule and also on whether the host monolayer was DPPC or DPPG. For DPPC, the pharmaceutical drugs were expelled at varying degrees from the interface at high surface pressures, and there was a maximum drug concentration above which the effects saturated, probably because the molecules in excess were lost to the subphase. These critical concentrations were 2mol% for DIP and CPZ and 5mol% for TFP. For DIP, in particular, the results from isotherm were correlated with in situ FTIR spectroscopy and fluorescent microscopy experiments, carried out by collaborators, which allowed the precise location of the drug to be determined. There is no insertion of DIP into the hydrophobic tail region of the DPPC monolayer, with interaction taking place with the phosphate group in the zwitterion, whose small changes in orientation induced by DIP lead to the large changes in dipole moment. Because DPPG is negatively charged on a pure water surface monolayer, there is no saturation of the expansion effects with the increase in drug concentration. The increase in the effective dipole moment of the mixed monolayers are attributed to alterations in the surface charge density by adsorption of the cationic drugs, which then reduces the negative contribution of the double-layer potential as compared to the pure DPPG monolayer. The results for COL and MEL must be considered separately owing to their distinct nature, even though a cooperative behavior was also observed with large effects at low concentrations. Both COL and MEL induce changes in the DPPC monolayers up to the highest concentration employed, viz. 20mol%. For COL, a condensation effect was observed at low concentrations, which was followed by monolayer expansion at high concentrations, thus confirming previous results in the literature. All COL/DPPG monolayers were more expanded than pure DPPG, also confirming previous results from the literature. While the interaction of MEL with DPPC was essentially similar to that of COL, in spite of the fact that MEL does not form stable monolayers on its own, its interaction with DPPG was somewhat peculiar in that the effects it induced saturate at 5mol%. This also differs from the behavior of the pharmaceutical drugs. MEL is neutral over a wide range of pHs, and therefore its interaction with DPPC and DPPG monolayers must occur via dipole interaction. The same applies to COL, and this explains why the behavior of these two substances is different from the drugs (DIP, CPZ and TFP) that are charged on the water surface, in the interaction with DPPC and DPPG.

A interação de várias substancias bioativas com monocamadas de fosfolipídios foi investigada usando isotermas de pressão e potencial de superfície, incluindo as drogas farmacológicas dipiridamol (DIP), clopromazina (CPZ) e trifluoperazina (TFP), além da melatonina (MEL) e o colesterol (COL). Os fosfolipídios empregados foram o zwiteriônico dipalmitoil fosfatidil colina (DPPC) e o aniônico dipalmitoil fosfatidil glicerol (DPPG) espalhados na superfície de água ultrapura, sendo que as monocamadas servem como modelo simples de membranas. A cooperatividade na interação entre fosfolipídios e moléculas com atividade biológica foi essencial para entender os acentuados efeitos na expansão (ou condensação) das monocamadas e as mudanças no momento de dipolo (até 10% de aumento na expansão em relação à monocamada do fosfolipídio puro para as misturas DIP/DPPC) que ocorreram a concentrações molares muito baixas entre 0,2-0,4% do DIP. Tais efeitos foram observados para todas as cinco substâncias investigadas, em todos os regimes de pressão. Nas altas concentrações, o comportamento da interação depende do tipo de mólecula e também de se a monocamada é de DPPC ou DPPG. Para o DPPC, as drogas farmacológicas foram expelidas da interface em vários graus a altas pressões, e existia um máximo de concentração da droga acima do qual ocorria a saturação, provavelmente porque as moléculas em excesso foram para a subfase. Essas concentrações críticas foram de 2% em mol para o DIP e a CPZ e de 5% em mol para a TFP. Para o DIP, em particular, os resultados das isotermas foram correlacionados com experimentos de espectroscopia de FTIR e microscopia de fluorescência \"in situ\", realizados por colaboradores, os quais permitiram a determinação de uma localização precisa da droga estudada. Não existe inserção do DIP na região da cauda hidrofóbica da monocamada do DPPC, com a interação ocorrendo com o grupo fosfato no zwiteríon, cujas pequenas mudanças na orientação induzidas pelo DIP levam a grandes mudanças no momento de dipolo. Como o DPPG está carregado negativamente sobre a superfície da água pura, não existe saturação nos efeitos de expansão com o aumento da concentração das drogas. O aumento do momento de dipolo efetivo na monocamada mista é atribuído a alterações na densidade de carga superficial pela adsorção da droga catiônica, que reduz a contribuição negativa do potencial da dupla camada, quando comparado com o da monocamada de DPPG puro. Os resultados do COL e a MEL devem ser considerados separadamente devido a sua natureza distinta, embora um comportamento cooperativo também tenha observado com grandes efeitos nas baixas concentrações. Tanto o COL como o MEL induzem mudanças na expansão das monocamadas de DPPC até a máxima concentração empregada, 20% molar. Para o COL foi observado um efeito de condensação a baixas concentrações, o qual foi seguido por uma expansão a altas concentrações, confirmando assim resultados prévios da literatura. Todas as monocamadas mistas COL/DPPG apresentavam-se expandidas, também confirmando alguns resultados da literatura para lipídios (diferentes do DPPC) quando misturados com o COL. A interação da MEL com o DPPC foi essencialmente similar à do COL, apesar do fato de a MEL pura não formar monocamadas estáveis. Sua interação com o DPPG foi peculiar já que o efeito que esta induz satura a 5% em mol. Isto também difere do comportamento das drogas farmacológicas. A MEL é neutra em todos os pHs, portanto, sua intenção com as membranas modelo de DPPG e DPPC só pode ocorrer via dipolo. O mesmo se aplica ao colesterol, o que justifica as diferenças no comportameto destas duas moléculas quando comparadas com as drogas (DIP, CPZ, TFP), que são carregadas sobre a água pura, nas misturas com os dois fosfolipídios (DPPG e DPPC). / The interaction of various bioactive substances with phospholipids monolayers has been investigated using surface pressure and surface potential isotherms, which include the pharmaceutical drugs dipyridamole (DIP), chlorpromazine (CPZ) and trifluoperazine (TFP), in addition to melatonin (MEL) and cholesterol (COL). The phospholipids employed were the zwitterionic dipalmitoyl phosphatidyl choline (DPPC) and the anionic dipalmitoyl phosphatidyl glycerol (DPPG) spread onto ultra pure water surfaces, where the monolayers served as simple model membrane systems. Cooperativity in the interaction between phospholipid and bioactive molecules was essential to account for the large effects of expansion (up to 10% increase in area in relation to the pure phospholipid monolayer for the DIP/DPPC mixture) of the monolayers and changes in dipole moment, which occurred at very low concentrations, e.g. 0.2 - 0.4 mol% of the substance. Such large effects were observed for all 5 substances investigated, at all surface pressure regimes. At higher concentrations, the interaction behavior depended on the type of molecule and also on whether the host monolayer was DPPC or DPPG. For DPPC, the pharmaceutical drugs were expelled at varying degrees from the interface at high surface pressures, and there was a maximum drug concentration above which the effects saturated, probably because the molecules in excess were lost to the subphase. These critical concentrations were 2mol% for DIP and CPZ and 5mol% for TFP. For DIP, in particular, the results from isotherm were correlated with in situ FTIR spectroscopy and fluorescent microscopy experiments, carried out by collaborators, which allowed the precise location of the drug to be determined. There is no insertion of DIP into the hydrophobic tail region of the DPPC monolayer, with interaction taking place with the phosphate group in the zwitterion, whose small changes in orientation induced by DIP lead to the large changes in dipole moment. Because DPPG is negatively charged on a pure water surface monolayer, there is no saturation of the expansion effects with the increase in drug concentration. The increase in the effective dipole moment of the mixed monolayers are attributed to alterations in the surface charge density by adsorption of the cationic drugs, which then reduces the negative contribution of the double-layer potential as compared to the pure DPPG monolayer. The results for COL and MEL must be considered separately owing to their distinct nature, even though a cooperative behavior was also observed with large effects at low concentrations. Both COL and MEL induce changes in the DPPC monolayers up to the highest concentration employed, viz. 20mol%. For COL, a condensation effect was observed at low concentrations, which was followed by monolayer expansion at high concentrations, thus confirming previous results in the literature. All COL/DPPG monolayers were more expanded than pure DPPG, also confirming previous results from the literature. While the interaction of MEL with DPPC was essentially similar to that of COL, in spite of the fact that MEL does not form stable monolayers on its own, its interaction with DPPG was somewhat peculiar in that the effects it induced saturate at 5mol%. This also differs from the behavior of the pharmaceutical drugs. MEL is neutral over a wide range of pHs, and therefore its interaction with DPPC and DPPG monolayers must occur via dipole interaction. The same applies to COL, and this explains why the behavior of these two substances is different from the drugs (DIP, CPZ and TFP) that are charged on the water surface, in the interaction with DPPC and DPPG.

<p>Cyclobutane pyrimidine dimers (CPD) are the predominant DNA lesions formed upon exposure of this biopolymer to sunlight. Given the potentially dire biological consequences of DNA lesions, there is a need to fully characterize their behaviour, with an eye towards understanding their complete reactivity and as a possible means to detect and quantify their presence in the genome. The work described in this dissertation describes studies of the alkaline reactivity of CPD lesions generated within dinucleotide & polynucleotide strands. It was found that CPD-TpT is generally inert under alkaline conditions at room temperature, which is in agreement with earlier studies on alkaline hydrolysis of CPD-thymine and CPD-thymidine. However, a re-evaluation of the same reaction in the presence of ¹⁸O labelled water demonstrated that, similar to other UV-induced DNA lesions containing a saturated pyrimidine ring, CPD undergoes a water addition at the C4=O group of the nucleobase leading to the formation of a hemiaminal intermediate. This intermediate, however, does not lead to hydrolysis products and completely reverts to starting material under those same conditions. Moreover, the two C4=O groups present on 3′ and 5′-thymines in a CPD molecule show different chemical reactivities, with the 3′ C4=O group having greater affinity towards water addition as compared to the one on 5′ end, a fact reflected in different rates of exchange with the incoming nucleophile leading to the hemiaminal intermediate. The ¹⁸O labelling reaction was also investigated in CPD lesions generated within oligonucleotides to probe the cause of asymmetry between the 3′ <i>vs</i> 5′ C4=O groups; ultimately, it was determined that the asymmetric reactivity observed to occur between the two C4=O groups was an intrinsic property of the CPD molecule and did not arise as a result of asymmetry in a dinucleotide setting.</p><p><br></p> <p>In addition to the above studies, during the course of the investigation of the nucleophilic reactivity of CPD, a chemical reaction was observed leading to what appeared to be the rapid and total chemical reversal of CPD lesions to the original TpT (thymine-thymine dinucleotide)! This “repair” reaction occurred when CPD reacted with hydrazine, and appears facilitated by an inert atmosphere under which it rapidly proceeds to completion at room temperature.</p><br>

<p> The study of proteasome is a rapidly evolving field with multifaceted implications in neuroscience, aging, and cancer. Recent developments structural biology of the proteasome machinery has catapulted the drug discovery and targeted protein degradation. The success of proteasome inhibitors like Bortezomib and Ixazomib has also led to new interests in developing more precise inhibitors for the various proteasome isoforms. Proteasome activation is a relatively new field, and much has to be done in the field. The 20S CP is an emerging target in chemical biology and drug discovery for its implications in maintaining protein homeostasis and immune regulation. The central theme of the thesis is to study the proteasome in cellular contexts to develop new chemical biology tools to study the proteasome and its modulation by small molecules and probes in cellular contexts to ameliorate protein accumulation-mediated neurodegeneration </p>

<p dir="ltr">Cancer is the second leading cause of death worldwide, and there is a continued need for effective treatments to combat the disease. A key challenge in cancer therapy persists in the form of therapeutic resistance. While kinase inhibitors (KIs) have shown promise in treating cancer patients with dysregulated protein kinases, treatment failures are common, highlighting the urgent need to address this issue. Despite the approval of 80 protein kinase inhibitors by the United States Food and Drug Administration (FDA), and numerous others in clinical trials, the chemical space explored for protein kinase inhibitors remains limited. Most FDA-approved kinase inhibitors share common core moieties, such as indazole, quinoline, pyrazole, and pyrimidine, indicating a lack of diversification in drug development in this area.</p><p dir="ltr">Efforts to expand the chemical space have led to the identification of a novel 3<i>H</i>-pyrazolo-[4,3-<i>f</i>]quinoline core by the Sintim group. This scaffold can be efficiently synthesized through the Doebner–Povarov multicomponent reaction using readily available ketones, heteroaromatic aldehydes, and 5-aminoindazole. This multicomponent chemistry affords small molecules which inhibit disease-associated protein kinases with sub-nanomolar IC₅₀ values. Additionally, the scaffold presents a unique opportunity to tune for selectivity via judicious substitution patterns, allowing us to target numerous disease-driving kinases, such as FLT3, haspin, and CLK, with the use of simple multi-component chemistry.</p><p dir="ltr">From this work emerged lead amide-containing compound HSK205, which potently inhibits FLT3 and haspin and shows impressive potencies against FLT3-driven acute myeloid leukemia cell lines, with GI₅₀ values between 2 and 20 nM. Western blot analyses indicate that HSK205 inhibits the phosphorylation of FLT3 and histone H3 (substrate of haspin) in Molm-14 AML cells. Further exploration led to the discovery of lead CLK inhibitors, such as HSK1132 and HSK3110, which inhibit the growth of multiple myeloma cell lines <i>in vitro</i> with GI₅₀ values as low as 17 nM. Additionally, these compounds are orally bioavailable and reduce the growth of multiple myeloma RPMI-8226 xenograft model in mice by 69%.</p>

<p dir="ltr">UBE2C is upregulated in castration-resistant prostate cancer and shows strong correlation with high tumor grade. Currently, the scarcity of UBE2C inhibitors is alarming. This study is the first to report UBE2C post-translational modulation mediated by LIMK2 kinase. A proteome-wide screen previously conducted in the Shah lab has identified UBE2C as a direct substrate of LIMK2 using an innovative chemical genetic approach. LIMK2 regulates UBE2C in a variety of ways. First, LIMK2 directly associates with UBE2C in cells. Second, LIMK2 phosphorylates UBE2C at S123 and increases its stability at the protein level. Third, LIMK2 upregulates UBE2C mRNA and protein expression levels in cells. Contrary to its well-established function as an enzyme involved in the ubiquitin-proteosome pathway, UBE2C stabilizes LIMK2 protein expression in a reciprocal loop. This study is the first to show UBE2C stabilizing its substrate. Likewise, UBE2C increases LIMK2 mRNA and protein levels; however, the mechanism is to be elucidated. LIMK2-UBE2C loop is extremely oncogenic creating CRPC pathogenesis <i>in vivo</i>. Targeting LIMK2 is a suitable approach to effectively degrade both UBE2C and LIMK2 which leads to significant inhibition of tumor formation, cancer stem cell phenotype and epithelial to mesenchymal transition <i>in vivo</i>. Additionally, CDK1 for the longest time was thought to be the only protein of the cyclin dependent kinase family which binds to and is activated by cyclin B1 to regulate cell cycle progression. We first showed CDK5 activity in cell division and its importance in maintaining mitotic fidelity. We first established the activation of CDK5 by cyclin B1 <i>in vitro</i>. The phospho-mimetic CDK5 was observed to be less active when bound to cyclin B1 than its wild-type counterpart.</p>

Simulations of various hydration levels of lamellar phase 23:2 Diyne PC were performed, and subsequent, serial docking simulations of a tyrosine monomer were replicated for each system in both hydrated and dehydrated states.<br>The goal was to evaluate how hydration impacts self-assembly and crystallization on the surface, and<br>whether or not these simulations, when run sequentially, could determine the answer. It was discovered that hydrated and dehydrated surfaces behave differently, and that<br>headgroup orientation plays a role in the initial docking and self-assembly process of the tyrosine monomer. It was also determined that potential energy as a sole metric<br>for determining whether or not a specific conformation of intermolecular orientation is not entirely useful, and docking scores are likely useful metrics in discriminating between conformations with identical potential energy values. <br>

Decytospolides A and B are natural products isolated from Cytospora sp. No ZW02 that show mild anticancer properties. The interest in synthesizing these compound lies not in their activities, but rather the simplicity of the structure which could easily be modified to provide more potent derivatives. Previous syntheses of these compounds relied on transition metals to install the tetrahydropyran core or extensive use of protecting groups. Our first generation synthesis made use of the Achmatowicz rearrangement to synthesize the tetrahydropyran moiety. Based on this, a concise, protecting group free synthesis has been accomplished utilizing the Achmatowicz rearrangement of an optically active furanyl alcohol followed by diastereoselective Kishi reduction of the resulting dihydropyranone hemiacetal. <br><br>Carambolaflavone A is a natural product isolated from A. carambola with antidiabetic properties. Notably, these compound promote both insulin secretion and glucose uptake by muscle cells in hyperglycemic rats. A previous synthesis has been reported by Wang and coworkers, however this synthesis does not offer much potential for the formation of derivatives and relies on a C-glycosylation that requires heating for regio- and diastereoselectivity. Progress towards a concise synthesis has been made featuring a Lewis acid promoted highly diastereoselective substrate controlled C-glycosylation that does not require heating and a one pot oxidation of chroman to chromone utilizing DDQ. Further research is underway to complete the synthesis of this molecule by an oxidative addition to the chromone and subsequent removal of protecting groups.

<p>Pathogenic bacteria present a critical threat to modern medicine. Therapeutic strategies to target and eliminate resilient bacteria are not advancing at the same rate as the emergence of bacterial resistance. An associated urgent concern regarding antibiotic resistance is the existence and proliferation of intracellular bacteria, which find refuge from bactericidal mechanisms by hiding within mammalian cells. Therefore, many once-successful antibiotics become ineffective through the development of resistance, or through failure to reach intracellular locations in therapeutic concentration. To overcome these challenges, the covalent combination of a conventional antibiotic with an antibiotic, cell-penetrating peptide was explored to develop dual-action antibiotic conjugates. </p> <p>Herein, we utilized a strategy in conjugating the antibiotics by a cleavable linkage to cationic amphiphilic polyproline helices (CAPHs) to improve vancomycin and linezolid antibiotics. This approach enables the conjugate to penetrate cells and deliver two potent monomeric antimicrobial drugs. The vancomycin-CAPH conjugate, <b>VanP14S</b>, showed enhanced mammalian cell uptake compared to vancomycin, a poor mammalian cell-penetrating agent; and <b>VanP14S</b> was capable of cleaving and releasing two antibiotics under mimicked physiological conditions. Enhanced antibacterial activity was observed against a spectrum of Gram-positive and Gram-negative pathogens, including drug-resistant strains. Further investigation revealed that this conjugate’s bactericidal activity was not entirely the result of significant membrane perturbation such as a lytic mode of action. Mammalian cell toxicity and red blood cell lysis were insignificant at relevant bactericidal concentrations below 20 µM. The current results suggest an enhanced binding to the peptidoglycan of bacteria, the target of vancomycin, although more work is needed to justify this claim. Preliminary results on <b>VanP14GAPS</b>, a conjugate with a more rigid CAPH, convey similar activity to <b>VanP14S; </b>however,<b> </b>moderate increases in red blood cell lysis and cytotoxicity were observed. </p> <p>Regarding the <b>LnzP14</b> conjugate, preliminary data reveal that the conjugate has Gram-negative activity against <i>Escherichia coli</i>, whereas linezolid is ineffective in killing Gram-negative bacteria. This conjugate showed significant enhancement in cellular uptake compared to the CAPH, and the release of linezolid and CAPH in physiological conditions was confirmed. Overall, arming a conventional antibiotic with an antimicrobial, cell-penetrating peptide appears to be a powerful strategy in providing novel antibiotic conjugates with the propensity to overcome the limitations in treating challenging pathogens.</p>